Edible sensor delivers real-time antiretroviral dosage data
Edible sensor delivers real-time antiretroviral dosage data
HIV patients received real-time antiretroviral dosage data from an innovative edible sensor in a clinical trial.
An innovative ingestible sensor technology tested in an interventional clinical trial provided HIV patients with real-time antiretroviral dosage data, enabling them to better control their infection.
The drug regimen for 130 HIV patients was monitored by the Proteus Digital Health Feedback (PDHF) Information Technology system, which let patients know in real-time when a dose of medication had been taken. Data showed the participants were more adherent to antiretrovirals (ARVs), enabling them to experience lower viral loads.
The study is one of earliest that uses an FDA-approved ingestible sensor system for ARV therapy in HIV-infected adults. The findings are a significant step in measuring and monitoring medication adherence in HIV patients and developing real-time interventions to improve patient adherence
For additional information: https://www.europeanpharmaceuticalreview.com/news/176506/edible-sensor-delivers-real-time-antiretroviral-dosage-data/